Pricing Log in Create free account

Longeveron Inc. (LGVN) vs Orgenesis Inc. (ORGS)

Longeveron Inc. and Orgenesis Inc. are both Biotechnology companies. Longeveron Inc. and Orgenesis Inc. are of similar size ($5.7M and $5.5M). Orgenesis Inc. grew revenue faster over the last twelve months: 95.3% against −42.7%. Longeveron Inc. has the higher net margin (−1,977.6% vs −4,653.6%) and the lower return on invested capital (−4,549.0% vs 0.00%). Across the 17 metrics below, Longeveron Inc. leads on 9 and Orgenesis Inc. on 8.

Valuation

Metric LGVN ORGS Biotechnology median
P/E n/m n/m 10.60
P/S 4.73 1.42 9.40
P/B 0.54 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 n/m 0.66
EV/Sales (3.10) 16.89 9.02
Earnings yield (568.59%) (3,288.57%) (32.88%)
Free cash flow yield (371.04%) (1,176.50%) (23.13%)

Profitability

Metric LGVN ORGS Biotechnology median
Gross margin 69.76% (86.28%) 68.51%
Operating margin (1,992.84%) (3,842.32%) 0.00%
Net margin (1,977.59%) (4,653.62%) 0.00%
Free cash flow margin (1,755.69%) (1,675.27%) 0.00%
Return on equity (203.61%) 164.62% (51.96%)
Return on assets (145.64%) (605.73%) (46.06%)
Return on invested capital (4,549.04%) 0.00% 0.00%

Growth

Metric LGVN ORGS Biotechnology median
Revenue growth (TTM) (42.74%) 95.28% 6.76%
EPS growth (last fiscal year) 50.76% 40.10% 29.88%
Revenue growth, 5-year CAGR (26.60%) (23.30%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LGVN ORGS Biotechnology median
Debt to equity 0.00 (0.44) 0.00
Current ratio 2.63 0.03 4.97
Net debt to EBITDA 0.20 (0.42) 1.01

Dividend

Metric LGVN ORGS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LGVN ORGS Biotechnology median
Market cap 5.45m 5.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack